Published: Sat, January 13, 2018
Worldwide | By Isabel Fisher

Boston Scientific Corporation (NYSE:BSX)

The stock increased 0.51% or $0.2866 during the last trading session, reaching $56.9666. Marco Investment Management Llc sold 3,955 shares as Us Bancorp Del (USB)'s stock declined 6.89%. General Electric Company (NYSE:GE) has declined 4.46% since January 11, 2017 and is downtrending. It has underperformed by 4.60% the S&P500.

Stuart Weisbrod increased its stake in Boston Scientific Corp (BSX) by 127.27% based on its latest 2017Q3 regulatory filing with the SEC. Point72 Asset Management LP reported 125,500 shares. Iguana Healthcare Management Llc who had been investing in Boston Scientific Corp for a number of months, seems to be bullish on the $37.76 billion market cap company. The firm owned 30,923,730 shares of the company's stock after buying an additional 310,828 shares during the period. About 44,732 shares traded. It has outperformed by 2.42% the S&P500.

(M) worth $639.42 million at the end of the most recent reporting period.The investor is now holding 25,898,082 shares thanks to an increase of 517,779 new shares in their portfolio. Its up 0.01, from 1.03 in 2017Q2. It worsened, as 112 investors sold GE shares while 818 reduced holdings. 63 funds opened positions while 84 raised stakes. Private Advisor Gp Ltd Liability Corp has 18,863 shares for 0.01% of their portfolio. Boston Scientific has a twelve month low of $23.03 and a twelve month high of $29.93.

Boston Scientific (NYSE:BSX) last posted its quarterly earnings results on Thursday, October 26th. The insider, THEPAUT ERIC FRANCIS YVES, now holds 116,562 shares of BSX. Wedbush maintained Boston Scientific Corporation (NYSE:BSX) rating on Friday, July 29. Boston Scientific's quarterly revenue was up 5.6% on a year-over-year basis. research analysts forecast that Boston Scientific will post 1.25 EPS for the current fiscal year. According to their observations and findings, the stock could provide a high EPS of $0.35/share and a low EPS of $0.32/share. JPMorgan Chase & Co. reiterated a "buy" rating on shares of Boston Scientific in a report on Wednesday, November 29th.

Ladenburg Thalmann Financial Services Inc. lessened its position in shares of Boston Scientific Corporation (NYSE:BSX) by 12.1% in the third quarter, according to the company in its most recent Form 13F filing with the SEC.

Relative strength index (RSI-14) for Boston Scientific Corporation (BSX) is at 69.04. Jefferies Grp Incorporated Lc holds 3,058 shares. Ig Inv Mngmt owns 0.01% invested in Boston Scientific Corporation (NYSE:BSX) for 68,000 shares.

Boston Scientific Corporation (NYSE:BSX) reported its EPS in the last quarter as $0.31/Share lagging the analyst estimate of $0.31/Share by a difference of $0. Therefore 79% are positive. Analysts have placed a $31.14 price target on Boston Scientific Corporation, suggesting a 13.15% gain from recent close. The firm earned "Buy" rating on Thursday, August 20 by Roth Capital. The stock of Boston Scientific Corporation (NYSE:BSX) earned "Hold" rating by Oppenheimer on Wednesday, August 9. The firm has "Buy" rating by Needham given on Friday, February 3. The firm has "Buy" rating given on Friday, February 3 by Needham. The rating was maintained by Stifel Nicolaus with "Buy" on Monday, September 25. TheStreet lowered Boston Scientific from a b rating to a c+ rating in a report on Thursday, December 7th. The rating was maintained by Oppenheimer on Wednesday, August 9 with "Hold". Stifel Nicolaus maintained the shares of BSX in report on Tuesday, August 1 with "Buy" rating. Finally, BMO Capital Markets restated a "buy" rating and set a $32.00 price objective on shares of Boston Scientific in a research report on Tuesday, December 12th. Cim Investment Mangement Inc bought 9,568 shares as the company's stock rose 5.21% with the market. Another trade for 15,500 shares valued at $416,559 was sold by Phalen Michael P. Nanavaty Maulik sold $1.56 million worth of Boston Scientific Corporation (NYSE:BSX) on Wednesday, August 30. Schroder Investment Management Group now owns 275,180 shares of the medical equipment provider's stock worth $7,656,000 after purchasing an additional 8,623 shares during the last quarter. Sorenson John Bradley sold $208,328 worth of stock. The insider Gifford Craig E sold $15,927. The insider Carruthers Wendy sold 12,433 shares worth $332,584. Kemnay Advisory holds 1,900 shares.

Investors sentiment decreased to 1.18 in 2017 Q3. Its down 0.01, from 0.9 in 2017Q2. It fall, as 19 investors sold POR shares while 78 reduced holdings. 81 funds opened positions while 368 raised stakes. Robecosam Ag invested in 1.07% or 483,901 shares. 9,958 were reported by Bbr Ptnrs Ltd Liability Corporation. Dupont Capital Mgmt has 0.06% invested in General Electric Company (NYSE:GE). (NYSE:ECL). Van Strum & Towne invested in 3.55% or 42,453 shares. BLACKROCK INC. owned 2.04% of Macy's, Inc. California State Teachers Retirement Sys accumulated 94,770 shares or 0.01% of the stock. (NYSE:ECL) for 448,113 shares. Citadel Ltd Llc holds 0.05% or 2.08 million shares in its portfolio. Cambridge Rech accumulated 5,650 shares. Old Point Service N A has invested 1.55% in Ecolab Inc. Oakworth Cap Inc owns 170 shares for 0% of their portfolio. 1,600 are held by Dt Invest Partners Ltd Com. SunTrust Banks reaffirmed a buy rating and issued a $34.00 price objective on shares of Boston Scientific in a research report on Monday, October 2nd. Lehman Fincl holds 0.15% in Sarepta Therapeutics, Inc.

Since August 1, 2017, it had 0 insider purchases, and 13 insider sales for $15.16 million activity. GATES WILLIAM H III bought $10.01 million worth of Ecolab Inc. The insider Pratt Timothy A. sold 10,104 shares worth $277,475.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Like this: